Chronic Viral Illness Service/Royal Victoria Hospital/McGill University Health Centre (MUHC)

Montreal, Quebec H4A 3JI

0 studies enrolling now · 3 studies all time

What they study most

Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis

Studies at this site

• Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD) — Completed
• Safety and Efficacy of Selonsertib in Adults With Nonalcoholic Steatohepatitis (NASH) and Bridging (F3) Fibrosis — Stopped early
• Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Stopped early